These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074 [TBL] [Abstract][Full Text] [Related]
4. The effects of clozapine on cognitive functioning in schizophrenia. McGurk SR J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607 [TBL] [Abstract][Full Text] [Related]
5. Relationships between changes in symptom ratings, neurophysiological test performance and quality of life in schizophrenic patients treated with clozapine. Galletly CA; Clark CR; McFarlane AC; Weber DL Psychiatry Res; 1997 Oct; 72(3):161-6. PubMed ID: 9406905 [TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia. Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702 [TBL] [Abstract][Full Text] [Related]
7. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine. Krzystanek M; Krupka-Matuszczyk I Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416 [TBL] [Abstract][Full Text] [Related]
9. The effects of clozapine on negative symptoms in patients with schizophrenia with minimal positive symptoms. Brar JS; Chengappa KN; Parepally H; Sandman AR; Kreinbrook SB; Sheth SA; Ganguli R Ann Clin Psychiatry; 1997 Dec; 9(4):227-34. PubMed ID: 9511946 [TBL] [Abstract][Full Text] [Related]
10. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012). Li Q; Xiang YT; Su YA; Shu L; Yu X; Correll CU; Ungvari GS; Chiu HF; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM; Kane JM Schizophr Res; 2015 Oct; 168(1-2):523-9. PubMed ID: 26277534 [TBL] [Abstract][Full Text] [Related]
11. Clozapine: a distinct, poorly understood and under-used molecule. Joober R; Boksa P J Psychiatry Neurosci; 2010 May; 35(3):147-9. PubMed ID: 20420765 [No Abstract] [Full Text] [Related]
12. Symptom domains of schizophrenia: the role of atypical antipsychotic agents. Burton S J Psychopharmacol; 2006 Nov; 20(6 Suppl):6-19. PubMed ID: 17046984 [TBL] [Abstract][Full Text] [Related]
13. Clozapine: a clinical review of adverse effects and management. Iqbal MM; Rahman A; Husain Z; Mahmud SZ; Ryan WG; Feldman JM Ann Clin Psychiatry; 2003 Mar; 15(1):33-48. PubMed ID: 12839431 [TBL] [Abstract][Full Text] [Related]
14. Schizophrenia past clozapine: what works? Mustafa FA J Clin Psychopharmacol; 2013 Feb; 33(1):63-8. PubMed ID: 23277242 [TBL] [Abstract][Full Text] [Related]
15. [Clozapine and treatment of negative symptoms]. Lançon C; Farisse J; Llorca PM Encephale; 1997 Sep; 23 Spec No 4():7-11. PubMed ID: 9417403 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials. Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684 [TBL] [Abstract][Full Text] [Related]
17. Clozapine: current status and role in the pharmacotherapy of schizophrenia. Remington GJ; Addington D; Collins EJ; Jones BD; Lalonde P; MacCrimmon DJ; MacEwan GW Can J Psychiatry; 1996 Apr; 41(3):161-6. PubMed ID: 8722645 [TBL] [Abstract][Full Text] [Related]
18. [Leponex, 10 years after -- a clinical review]. Llorca PM; Pere JJ Encephale; 2004; 30(5):474-91. PubMed ID: 15627052 [TBL] [Abstract][Full Text] [Related]
19. Treatment refractory schizophrenia: how should we proceed? Sharif ZA Psychiatr Q; 1998; 69(4):263-81. PubMed ID: 9793107 [TBL] [Abstract][Full Text] [Related]
20. Effects of clozapine on psychiatric symptoms, cognition, and functional outcome in schizophrenia. Manschreck TC; Redmond DA; Candela SF; Maher BA J Neuropsychiatry Clin Neurosci; 1999; 11(4):481-9. PubMed ID: 10570762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]